Roles of the nitric oxide signaling pathway in cardiac ischemic preconditioning against myocardial ischemia-reperfusion injury

Medical Science Monitor

Volumn 17, Issue 2, 2011, Pages

  Weerateerangkul, Punate ^a   Chattipakorn, Siriporn ^a,b   Chattipakorn, Nipon ^a,b  

^a Faculty of Medicine Chiang Mai University   (Thailand)

^b CHIANG MAI UNIVERSITY   (Thailand)

Author keywords

Heart; Ischemia reperfusion injury; Ischemic preconditioning; Nitric oxide

Indexed keywords

ADENOSINE RECEPTOR BLOCKING AGENT; BRADYKININ; CYCLIC GMP DEPENDENT PROTEIN KINASE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; FLAVINE MONONUCLEOTIDE; GUANYLATE CYCLASE; INDUCIBLE NITRIC OXIDE SYNTHASE; N(G) NITROARGININE METHYL ESTER; NEURONAL NITRIC OXIDE SYNTHASE; NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PHENYLISOPROPYLADENOSINE; POTASSIUM CHANNEL; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE;

ARTICLE; CORONARY ARTERY LIGATION; CYTOPLASM; HEART INFARCTION PREVENTION; HEART MITOCHONDRION; HEART MUSCLE FIBER MEMBRANE; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART PROTECTION; HUMAN; ISCHEMIC PRECONDITIONING; ISOLATED HEART; MITOCHONDRIAL PERMEABILITY; NONHUMAN; REPERFUSION INJURY; SARCOLEMMA; SIGNAL TRANSDUCTION;

EID: 79551718850     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: 10.12659/MSM.881385     Document Type: Article

References (93)

1. Downey JM, Davis AM, Cohen MV: Signaling pathways in ischemic preconditioning. Heart Fail Rev, 2007; 12(3-4): 181-88
2. Skyschally A, Schulz R, Heusch G: Pathophysiology of myocardial infarction: protection by ischemic pre- and postconditioning. Herz, 2008; 33(2): 88-100
3. Schaper W, Gorge G, Winkler B, Schaper J: The collateral circulation of the heart. ProgCardiovasc Dis, 1988; 31(1): 57-77
4. Matsumura K, Jeremy RW, Schaper J, Becker LC: Progression of myocardial necrosis during reperfusion of ischemic myocardium. Circulation, 1998; 97(8): 795-804
5. Ladilov YV, Siegmund B, Piper HM: Protection of reoxygenated cardiomyocytes against hypercontracture by inhibition of Na+/H+ exchange. Am J Physiol, 1995; 268(4 Pt 2): H1531-39
6. Crompton M: The mitochondrial permeability transition pore and its role in cell death. Biochem J, 1999; 341(Pt 2): 233-49
7. Cohen MV, Baines CP, Downey JM: Ischemic preconditioning: from adenosine receptor to KATP channel. Annu Rev Physiol, 2000; 62: 79-109
8. Murry CE, Jennings RB, Reimer KA: Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation, 1986; 74(5): 1124-36
9. Liu Y, Downey JM: Ischemic preconditioning protects against infarction in rat heart. Am J Physiol, 1992; 263(4 Pt 2): H1107-12
10. Guo Y, Wu WJ, Qiu Y et al: Demonstration of an early and a late phase of ischemic preconditioning in mice. Am J Physiol, 1998; 275(4 Pt 2): H1375-87
11. Cohen MV, Liu GS, Downey JM: Preconditioning causes improved wall motion as well as smaller infarcts after transient coronary occlusion in rabbits. Circulation, 1991; 84(1): 341-49
12. Strickler J, Jacobson KA, Liang BT: Direct preconditioning of cultured chick ventricular myocytes. Novel functions of cardiac adenosine A2a and A3 receptors. J Clin Invest, 1996; 98(8): 1773-79
13. Stefano G, Esch T, Bilfinger T, Kream R: Proinflammation and preconditioning protection are part of a common nitric oxide mediated process. Med Sci Monit, 2010; 16(6): RA125-30
14. Liu GS, Thornton J, Van Winkle DM et al: Protection against infarction afforded by preconditioning is mediated by A1 adenosine receptors in rabbit heart. Circulation, 1991; 84(1): 350-56
15. Wall TM, Sheehy R, Hartman JC: Role of bradykinin in myocardial preconditioning. J Pharmacol Exp Ther, 1994; 270(2): 681-89
16. Schultz JE, Rose E, Yao Z, Gross GJ: Evidence for involvement of opioid receptors in ischemic preconditioning in rat hearts. Am J Physiol, 1995; 268(5 Pt 2): H2157-61
17. Stefano GB, Neenan K, Cadet P et al: Ischemic preconditioning - an opiate constitutive nitric oxide molecular hypothesis. Med Sci Monit, 2001; 7(6): 1357-75
18. Goto M, Liu Y, Yang XM et al: Role of bradykinin in protection of ischemic preconditioning in rabbit hearts. Circ Res, 1995; 77(3): 611-21
19. Baker JE, Holman P, Gross GJ: Preconditioning in immature rabbit hearts: role of KATP channels. Circulation, 1999; 99(9): 1249-54
20. Hanafy KA, Krumenacker JS, Murad F: NO, nitrotyrosine, and cyclic GMP in signal transduction. Med Sci Monit, 2001; 7(4): 801-19
21. Lyamina NP, Dolotovskaya PV, Lyamina SV et al: Nitric oxide production and intensity of free radical processes in young men with high normal and hypertensive blood pressure. Med SciMonit, 2003; 9(7): CR304-10
22. Ziolo MT, Bers DM: The real estate of NOS signaling: location, location, location. Circ Res, 2003; 92(12): 1279-81
23. Barouch LA, Harrison RW, Skaf MW et al: Nitric oxide regulates the heart by spatial confinement of nitric oxide synthase isoforms. Nature, 2002; 416(6878): 337-39
24. Massion PB, Balligand JL: Modulation of cardiac contraction, relaxation and rate by the endothelial nitric oxide synthase (eNOS): lessons from genetically modified mice. J Physiol, 2003; 546(Pt 1): 63-75
25. Bruckdorfer R: The basics about nitric oxide. Mol Aspects Med, 2005; 26(1-2): 3-31
26. Jiang LH, Gawler DJ, Hodson N et al: Regulation of cloned cardiac L-type calcium channels by cGMP-dependent protein kinase. J BiolChem, 2000; 275(9): 6135-43
27. Wang H, Kohr MJ, Wheeler DG, Ziolo MT: Endothelial nitric oxide synthase decreases beta-adrenergic responsiveness via inhibition of the L-type Ca2+ current. Am J Physiol Heart Circ Physiol, 2008; 294(3): H1473-80
28. Wang H, Kohr, MJ, Traynham CJ, Ziolo MT: Phosphodiesterase 5 restricts NOS3/Soluble guanylatecyclase signaling to L-type Ca2+ current in cardiac myocytes. J Mol Cell Cardiol, 2009; 47: 304-14
29. Wang H, Kohr MJ, Traynham CJ et al: Neuronal nitric oxide synthase signaling within cardiac myocytes targets phospholamban. Am J Physiol Cell Physiol, 2008; 294(6): C1566-75
30. Han J, Kim N, Joo H et al: ATP-sensitive K(+) channel activation by nitric oxide and protein kinase G in rabbit ventricular myocytes. Am J Physiol Heart Circ Physiol, 2002; 283(4): H1545-54
31. Sasaki N, Sato T, Ohler A et al: Activation of mitochondrial ATPdependent potassium channels by nitric oxide. Circulation, 2000; 101(4): 439-45
32. Herring N, Rigg L, Terrar DA, Paterson DJ: NO-cGMP pathway increases the hyperpolarisation-activated current, I(f), and heart rate during adrenergic stimulation. Cardiovasc Res, 2001; 52(3): 446-53
33. Lonardo G, Cerbai E, Casini S et al: Atrial natriuretic peptide modulates the hyperpolarization-activated current (If) in human atrial myocytes. Cardiovasc Res, 2004; 63(3): 528-36
34. Williams MW, Taft CS, Ramnauth S et al: Endogenous nitric oxide (NO) protects against ischaemia-reperfusion injury in the rabbit. Cardiovasc Res, 1995; 30(1): 79-86
35. Woolfson RG, Patel VC, Neild GH, Yellon DM: Inhibition of nitric oxide synthesis reduces infarct size by an adenosine-dependent mechanism. Circulation, 1995; 91(5): 1545-51
36. Rakhit RD, Marber MS: Nitric oxide: an emerging role in cardioprotection? Heart, 2001; 86: 368-72
37. Zhao L, Weber PA, Smith JR et al: Role of inducible nitric oxide synthase in pharmacological "preconditioning" with monophosphoryl lipid A. J Mol Cell Cardiol, 1997; 29(6): 1567-76
38. Ferdinandy P, Szilvassy Z, Horvath LI et al: Loss of pacing-induced preconditioning in rat hearts: role of nitric oxide and cholesterol-enriched diet. J Mol Cell Cardiol, 1997; 29(12): 3321-33
39. Yang XM, Krieg T, Cui L et al: NECA and bradykinin at reperfusion reduce infarction in rabbit hearts by signaling through PI3K, ERK, and NO. J Mol Cell Cardiol, 2004; 36: 411-21
40. Marina Prendes MG, Gonzalez M, Savino EA, Varela A: Role of endogenous nitric oxide in classic preconditioning in rat hearts. Regul Pept, 2007; 139(1-3): 141-45
41. Nakano A, Liu GS, Heusch G et al: Exogenous nitric oxide can trigger a preconditioned state through a free radical mechanism, but endogenous nitric oxide is not a trigger of classical ischemic preconditioning. J Mol Cell Cardiol, 2000; 32(7): 1159-67
42. Lochner A, Marais E, Genade S, Moolman JA: Nitric oxide: a trigger for classic preconditioning? Am J Physiol Heart Circ Physiol, 2000; 279(6): H2752-65
43. Kanno S, Lee PC, Zhang Y et al: Attenuation of myocardial ischemia/ reperfusion injury by superinduction of inducible nitric oxide synthase. Circulation, 2000; 101(23): 2742-48
44. Zhao T, Xi L, Chelliah J et al: Inducible nitric oxide synthase mediates delayed myocardial protection induced by activation of adenosine A(1) receptors: evidence from gene-knockout mice. Circulation, 2000; 102(8): 902-7
45. Wang Y, Guo Y, Zhang SX et al: Ischemic preconditioning upregulates inducible nitric oxide synthase in cardiac myocyte. J Mol Cell Cardiol, 2002; 34(1): 5-15
46. Heinzel FR, Gres P, Boengler K et al: Inducible nitric oxide synthase expression and cardiomyocyte dysfunction during sustained moderate ischemia in pigs. Circ Res, 2008; 103: 1120-27
47. Guo Y, Jones WK, Xuan YT et al: The late phase of ischemic preconditioning is abrogated by targeted disruption of the inducible NO synthase gene. Proc Natl Acad Sci USA, 1998: 96(20): 11507-12
48. Bell RM, Yellon DM: The contribution of endothelial nitric oxide synthase to early ischaemic preconditioning: the lowering of the preconditioning threshold. An investigation in eNOS knockout mice.Cardiovasc Res, 2001; 52(2): 274-80
49. Guo Y, Li Q, Wu WJ et al: Endothelial nitric oxide synthase is not necessary for the early phase of ischemic preconditioning in the mouse. J Mol Cell Cardiol, 2008; 44: 496-501
50. du Toit EF, Genade S, Carlini S et al: Efficacy of ischaemic preconditioning in the eNOS overexpressed working mouse heart model. Eur J Pharmacol, 2007; 556(1-3): 115-20
51. Samouilov A, Kuppusamy P, Zweier JL: Evaluation of the magnitude and rate of nitric oxide production from nitrite in biological systems. Arch Biochem Biophys, 1998; 357(1): 1-7
52. Zweier JL, Wang P, Samouilov A, Kuppusamy P: Enzyme independent formation of nitric oxide in biological tissues. Nat Med, 1995; 1: 1796-801
53. Zweier JL, Samouilov A, Kuppusamy P: Non-enzymatic nitric oxide synthesis in biological systems. Biochim Biophys Acta, 1999; 250-62
54. Sun J, Morgan M, Shen RF et al: Mitochondrial energetics and calcium transport preconditioning results in S-nitrosylation of proteins involved in regulation of mitochondrial energetics and calcium transport. Circ Res, 2007; 101: 1155-63
55. Lin J, Steenbergen C, Murphy E, Sun J: Estrogen receptor-b activation results in S-nitrosylation of proteins involved in cardioprotection. Circulation, 2009; 120: 245-54
56. Foster MW, Stamler JS: New insight into protein S-nitrosylation: Mitochondria as a model system. J BiolChem, 2004; 279(24): 25891-97
57. Sun J: Protein S-nitrosylation: A role of nitric oxide signaling in cardiac ischemic preconditioning. Acta Physiol Sin, 2007; 59(5): 544-52
58. Lebuffe G, Schumacker PT, Shao ZH et al: ROS and NO trigger early preconditioning: relationship to mitochondrial KATP channel. Am J Physiol Heart Circ Physiol, 2003; 284(1): H299-308
59. Xu Z, Ji X, Boysen PG: Exogenous nitric oxide generates ROS and induces cardioprotection: involvement of PKG, mitochondrial KATP channels, and ERK. Am J Physiol Heart Circ Physiol, 2004; 286(4): H1433-40
60. + channels in rat hearts. Am J Physiol Heart Circ Physiol, 2006; 290(5): H1808-17
61. Cuong DV, Warda M, Kim N et al: Dynamic changes in nitric oxide and mitochondrial oxidative stress with site-dependent differential tissue response during anoxic preconditioning in rat heart. Am J Physiol Heart Circ Physiol, 2007; 293(3): H1457-65
62. Oldenburg O, Qin Q, Krieg T et al: Bradykinin induces mitochondrial ROS generation via NO, cGMP, PKG, and mitoKATP channel opening and leads to cardioprotection. Am J Physiol Heart Circ Physiol, 2004; 286(1): H468-76
63. Costa AD, Pierre SV, Cohen MV et al: cGMP signalling in pre- and postconditioning: the role of mitochondria. Cardiovasc Res, 2008; 77(2): 344-52
64. Javadov S, Karmazyn M, Escobales N: Mitochondrial permeability transition pore opening as a promising therapeutic target in cardiac diseases. J Pharmacol Exp Ther, 2009; 330(3): 670-78
65. Halestrap AP: A pore way to die: the role of mitochondria in reperfusion injury and cardioprotection. Biochem Soc Trans, 2010; 38(4): 841-60
66. Crompton M, Andreeva L: On the involvement of a mitochondrial pore in reperfusion injury. Basic Res Cardiol, 1993; 88: 513-23
67. Griffiths EJ, Halestrap AP: Protection by Cyclosporin A of ischemia/ reperfusion-induced damage in isolated rat hearts. J Mol Cell Cardiol, 1993; 25: 1461-69
68. Hausenloy DJ, Maddock HL, Baxter GF, Yellon DM: Inhibiting mitochondrial permeability transition pore opening: a new paradigm for myocardial preconditioning? Cardiovasc Res, 2002; 55: 534-43
69. Cuong DV, Kim N, Joo H et al: Subunit composition of ATP-sensitive potassium channels in mitochondria of rat hearts. Mitochondrion, 2005; 5(2): 121-33
70. Ljubkovic M, Shi Y, Cheng Q et al: Cardiac mitochondrial ATP-sensitive potassium channel is activated by nitric oxide in vitro. FEBS Lett, 2007; 581(22): 4255-59
71. Costa AD, Garlid KD, West IC et al: Protein kinase G transmits the cardioprotective signal from cytosol to mitochondria. Circ Res, 2005; 97(4): 329-36
72. Costa AD, Garlid KD: Intramitochondrial signaling: interactions among mitoKATP, PKCepsilon, ROS, and MPT. Am J Physiol Heart Circ Physiol, 2008; 295(2): H874-82
73. Das A, Xi L, Kukreja RC: Protein kinase G-dependent cardioprotective mechanism of phosphodiesterase-5 inhibition involves phosphorylation of ERK and GSK3beta. J Biol Chem, 2008; 283(43): 29572-85
74. Das A, Salloum FN, Xi L, Rao YJ, Kukreja RC: ERK phosphorylation mediates sildenafil-induced myocardial protection against ischemia-reperfusion injury in mice. Am J Physiol Heart Circ Physiol, 2009; 296(5): H1236-43
75. Miura T, Tanno M: Mitochondria and GSK-3b in cardioprotection against ischemia/reperfusion injury. Cardiovasc Drugs Ther, 2010, DOI 10.1007/s10557-010-6234-z
76. Fenger M, Haugaard SB, Andersen O et al: Is glycogen synthase kinase-3b an ultraconserved kernel enzyme? Gene Exp Genet Genomics, 2009; 2: 1-27
77. Juhaszova M, Zorov DB, Kim S-H et al: Glycogen synthase kinase-3b mediates convergence of protection signaling to inhibit the mitochondrial permeability transition pore. J Clin Invest, 2004; 113: 1535-49
78. Tong H, Imahashi K, Steenbergen C, Murphy E: Phosphorylation of glycogen synthase kinase-3beta during preconditioning through a phosphatidylinositol-3-kinase-dependent pathway is cardioprotective. Circ Res, 2002; 90: 377-79
79. Nishihara M, Miura T, Miki T et al: Erythropoietin affords additional cardioprotection to preconditioned hearts by enhanced phosphorylation of glycogen synthase kinase-3b. Am J Physiol Heart Circ Physiol, 2006; 291: H748-55
80. Gross ER, Hsu AK, Gross GJ: Opioid-induced cardioprotection occurs via glycogen synthase kinase beta inhibition during reperfusion in intact rat hearts. Circ Res, 2004; 94: 960-66
81. Obame FN, Plin-Mercier C, Assaly R et al: Cardioprotective effect of morphine and a blocker of glycogen synthase kinase 3 beta, SB216763 [3-(2, 4-dichlorophenyl)-4(1-methyl-1H-indol-3-yl)-1H-pyrrole-2, 5-dione], via inhibition of the mitochondrial permeability transitionpore. J Pharmacol Exp Ther, 2008; 326: 252-58
82. West MB, Rokosh G, Obal D et al: Cardiac myocyte-specific expression of inducible nitric oxide synthase protects against ischemia/reperfusion injury by preventing mitochondrial permeability transition. Circulation, 2008; 118(19): 1970-78
83. Andrukhiv A, Costa AD, West IC, Garlid KD: Opening mitoKATP increases superoxide generation from complex I of the electron transport chain. Am J Physiol Heart Circ Physiol, 2006; 291(5): H2067-74
84. Gomez L, Paillard M, Thibault H et al: Inhibition of GSK3beta by postconditioning is required to prevent opening of the mitochondrial permeability transition pore during reperfusion. Circulation, 2008; 117(21): 2761-68
85. Rickover O, Zinman T, Kaplan D, Shainberg A: Exogenous nitric oxide triggers classic ischemic preconditioning by preventing intracellular Ca2+ overload in cardiomyocytes. Cell Calcium, 2008; 43(4): 324-33
86. Lemasters JJ, Theruvath TP, Zhong Z, Nieminen AL: Mitochondrial calcium and the permeability transition in cell death. Biochim Biophys Acta, 2009; 1787(11): 1395-401
87. Ockaili R, Salloum F, Hawkins J, Kukreja RC: Sildenafil (Viagra) induces powerful cardioprotective effect via opening of mitochondrial K(ATP) channels in rabbits. Am J Physiol Heart Circ Physiol, 2002; 283(3): H1263-69
88. Salloum F, Yin C, Xi L, Kukreja RC: Sildenafil induces delayed preconditioning through inducible nitric oxide synthase-dependent pathway in mouse heart. Circ Res, 2003; 92(6): 595-97
89. Das A, Xi L, Kukreja RC: Phosphodiesterase-5 inhibitor sildenafil preconditions adult cardiac myocytes against necrosis and apoptosis. Essential role of nitric oxide signaling. J Biol Chem, 2005; 280(13): 12944-55
90. Salloum FN, Abbate A, Das A et al: Sildenafil (Viagra) attenuates ischemic cardiomyopathy and improves left ventricular function in mice. Am J Physiol Heart Circ Physiol, 2008; 294(3): H1398-406
91. Hu CP, Li YJ, Deng HW: The cardioprotective effects of nitroglycerininduced preconditioning are mediated by calcitonin gene-related peptide. Eur J Pharmacol, 1999; 369(2): 189-94
92. Mercanoglu G, Safran N, Gungor M et al: The effects of nebivolol on apoptosis in a rat infarct model. Circ J, 2008; 72(4): 660-70
93. Granfeldt A, Lefer DJ, Vinten-Johansen J: Protective ischaemia in patients: preconditioning and postconditioning. Cardiovasc Res, 2009; 83(2): 234-46